Last update 26 Feb 2026

GT-02037

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
glycosylated-SRIF, GSRIF, G SRIF 14
+ [2]
Target
GHR x SSTR
Action
antagonists, agonists
Mechanism
GHR antagonists(Growth hormone receptor antagonists), SSTR agonists(Somatostatin receptor agonists)
Therapeutic Areas
Nervous System DiseasesEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication
Acromegaly
Inactive Indication-
Originator Organization
Pharmaspur
Active Organization
PharmaspurGlyTech, Inc.GlyTech, Inc.
Inactive Organization-
License Organization
GlyTech, Inc.GlyTech, Inc.Guangzhou Winsun Pharmaceutical Co. Ltd.Guangzhou Winsun Pharmaceutical Co. Ltd.
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with GT-02037
JPRN-jRCT2080225152
/ CompletedPhase 1
Dose escalation study of single and multiple subcutaneous injections of GT-02037 in healthy Japanese adult males
JPRN-UMIN000028302
/ CompletedNot ApplicableIIT
Single-dose-administration study of GT-02037 subcutaneous injection in healthy Japanese male subjects - GT-02037 single dose study
100 Clinical Results associated with GT-02037
Login to view more data
100 Translational Medicine associated with GT-02037
Login to view more data
100 Patents (Medical) associated with GT-02037
Login to view more data
100 Deals associated with GT-02037
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AcromegalyPhase 2
Japan
GlyTech, Inc.GlyTech, Inc.
22 Jun 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free